These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26700460)

  • 1. Loss of 11βHSD1 enhances glycolysis, facilitates intrahepatic metastasis, and indicates poor prognosis in hepatocellular carcinoma.
    Liu X; Tan XL; Xia M; Wu C; Song J; Wu JJ; Laurence A; Xie QG; Zhang MZ; Liang HF; Zhang BX; Chen XP
    Oncotarget; 2016 Jan; 7(2):2038-53. PubMed ID: 26700460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
    Lei X; Li YF; Chen GD; Ou DP; Qiu XX; Zuo CH; Yang LY
    Oncotarget; 2015 Dec; 6(38):40622-41. PubMed ID: 26536663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSN5 upregulates glycolysis to promote hepatocellular carcinoma metastasis via stabilizing the HK2 protein.
    Huang M; Xiong H; Luo D; Xu B; Liu H
    Exp Cell Res; 2020 Mar; 388(2):111876. PubMed ID: 31991125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM.
    Zhou Y; Lin F; Wan T; Chen A; Wang H; Jiang B; Zhao W; Liao S; Wang S; Li G; Xu Z; Wang J; Zhang J; Ma H; Lin D; Li Q
    Theranostics; 2021; 11(12):5926-5938. PubMed ID: 33897890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
    Hirata H; Sugimachi K; Komatsu H; Ueda M; Masuda T; Uchi R; Sakimura S; Nambara S; Saito T; Shinden Y; Iguchi T; Eguchi H; Ito S; Terashima K; Sakamoto K; Hirakawa M; Honda H; Mimori K
    Cancer Res; 2016 Jun; 76(11):3265-76. PubMed ID: 27197151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling.
    Zhao YR; Wang JL; Xu C; Li YM; Sun B; Yang LY
    Clin Sci (Lond); 2019 Jul; 133(14):1645-1662. PubMed ID: 31278131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
    Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma.
    Cui M; Sun J; Hou J; Fang T; Wang X; Ge C; Zhao F; Chen T; Xie H; Cui Y; Yao M; Li J; Li H
    Tumour Biol; 2016 Oct; 37(10):13521-13531. PubMed ID: 27465557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
    Du R; Wu S; Lv X; Fang H; Wu S; Kang J
    J Exp Clin Cancer Res; 2014 Dec; 33(1):105. PubMed ID: 25499255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
    Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
    Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma.
    Shang R; Wang J; Sun W; Dai B; Ruan B; Zhang Z; Yang X; Gao Y; Qu S; Lv X; Tao K; Wang L; Dou K; Wang D
    Tumour Biol; 2016 Apr; 37(4):5097-105. PubMed ID: 26546438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated analyses identify miR-34c-3p/MAGI3 axis for the Warburg metabolism in hepatocellular carcinoma.
    Weng Q; Chen M; Yang W; Li J; Fan K; Xu M; Weng W; Lv X; Fang S; Zheng L; Song J; Zhao Z; Fan X; Ji J
    FASEB J; 2020 Apr; 34(4):5420-5434. PubMed ID: 32080912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway.
    Chen L; Guo P; He Y; Chen Z; Chen L; Luo Y; Qi L; Liu Y; Wu Q; Cui Y; Fang F; Zhang X; Song T; Guo H
    Cell Death Dis; 2018 May; 9(5):513. PubMed ID: 29725020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1.
    Hua S; Lei L; Deng L; Weng X; Liu C; Qi X; Wang S; Zhang D; Zou X; Cao C; Liu L; Wu D
    Oncogene; 2018 Mar; 37(12):1624-1636. PubMed ID: 29335523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.
    Luo G; Chao YL; Tang B; Li BS; Xiao YF; Xie R; Wang SM; Wu YY; Dong H; Liu XD; Yang SM
    Oncotarget; 2015 Nov; 6(35):37808-23. PubMed ID: 26498692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GRP78 activates the Wnt/HOXB9 pathway to promote invasion and metastasis of hepatocellular carcinoma by chaperoning LRP6.
    Xiong H; Xiao H; Luo C; Chen L; Liu X; Hu Z; Zou S; Guan J; Yang D; Wang K
    Exp Cell Res; 2019 Oct; 383(1):111493. PubMed ID: 31310747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoplasmic reticulum resident oxidase ERO1-Lalpha promotes hepatocellular carcinoma metastasis and angiogenesis through the S1PR1/STAT3/VEGF-A pathway.
    Yang S; Yang C; Yu F; Ding W; Hu Y; Cheng F; Zhang F; Guan B; Wang X; Lu L; Rao J
    Cell Death Dis; 2018 Oct; 9(11):1105. PubMed ID: 30377291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target.
    Chen DT; Pan JH; Chen YH; Xing W; Yan Y; Yuan YF; Zeng WA
    Br J Anaesth; 2019 Jun; 122(6):e157-e167. PubMed ID: 30915986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of PCK1 Gene Antagonizes Hepatocellular Carcinoma Through the Activation of Gluconeogenesis and Suppression of Glycolysis Pathways.
    Tang Y; Zhang Y; Wang C; Sun Z; Li L; Cheng S; Zhou W
    Cell Physiol Biochem; 2018; 47(1):344-355. PubMed ID: 29768256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of beta-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis.
    Liu L; Zhu XD; Wang WQ; Shen Y; Qin Y; Ren ZG; Sun HC; Tang ZY
    Clin Cancer Res; 2010 May; 16(10):2740-50. PubMed ID: 20460486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.